Chester County News and Community Website
JENKINTOWN, PA — SFA Therapeutics has installed Chairman Shawn Patrick O’Brien as chief executive officer as the biotechnology company prepares to advance its lead psoriasis drug into Phase 2 development …
SFA Therapeutics Shifts Leadership as Drug Programs Advance Read More JENKINTOWN, PA — SFA Therapeutics has secured a new U.S. patent covering a class of modified short-chain fatty acid compounds, strengthening intellectual property protection around its drug development platform and …
SFA Therapeutics Extends Patent Protection for Drug Platform Read More JENKINTOWN, PA — SFA Therapeutics, Inc. has announced encouraging results from its Phase 1b clinical trial of SFA-002, an oral drug candidate aimed at treating mild-to-moderate psoriasis. The study demonstrated both …
SFA Therapeutics Reports Promising Phase 1b Results for Oral Psoriasis Treatment Read More